Aviva PLC Neurocrine Biosciences Inc Transaction History

Aviva PLC

$36.8 Billion
Q4 2024

A detailed history of Aviva PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Aviva PLC holds 61,918 shares of NBIX stock, worth $6.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

61,918

Previous 24,092 157.01%

Holding current value

$6.82 Million

Previous $2.77 Million 204.76%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 13, 2025	BUY	$111.62 - $139.44 $4.22 Million - $5.27 Million	37,826 Added 157.01%	61,918 $8.45 Million
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $4.52 Million - $6.04 Million	-39,459 Reduced 62.09%	24,092 $2.77 Million
Q2 2024 Aug 02, 2024	SELL	$130.86 - $143.19 $184,643 - $202,041	-1,411 Reduced 2.17%	63,551 $8.75 Million
Q1 2024 May 14, 2024	BUY	$130.4 - $143.74 $781,617 - $861,577	5,994 Added 10.16%	64,962 $8.96 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $4.69 Million - $5.87 Million	44,182 Added 298.81%	58,968 $7.77 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $1.39 Million - $1.73 Million	14,786 New	14,786 $1.66 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $3.49 Million - $4.09 Million	-37,919 Reduced 67.77%	18,036 $1.92 Million
Q2 2022 Aug 04, 2022	BUY	$75.79 - $100.07 $4.24 Million - $5.6 Million	55,955 New	55,955 $5.45 Million
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $1.58 Million - $2.07 Million	-21,787 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$79.65 - $106.22 $1.74 Million - $2.31 Million	21,787 New	21,787 $1.86 Million
Q2 2021 Aug 10, 2021	SELL	$89.43 - $102.27 $1.25 Million - $1.43 Million	-13,950 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $65,677 - $89,550	750 Added 5.68%	13,950 $1.36 Million
Q4 2020 Feb 10, 2021	SELL	$86.91 - $108.33 $836,248 - $1.04 Million	-9,622 Reduced 42.16%	13,200 $1.27 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $444,547 - $624,798	4,623 Added 25.4%	22,822 $2.2 Million
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $1.88 Million - $2.89 Million	-22,144 Reduced 54.89%	18,199 $2.22 Million
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $1.77 Million - $2.69 Million	23,615 Added 141.17%	40,343 $3.49 Million
Q4 2019 Feb 10, 2020	BUY	$86.8 - $118.57 $1.45 Million - $1.98 Million	16,728 New	16,728 $1.8 Million

Others Institutions Holding NBIX

# of Institutions

656

Shares Held

96.6M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account